September 2026
1. PETERSEN TR, Hanson RS, Malkoski SP
   Letter by Petersen et al Regarding Article, "Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes From the STORM-PE Trial".
   Circulation. 2026;154:e339-e340.
   

   >> Share

   
   
2. LOOKSTEIN RA, Rosovsky RP
   Response by Lookstein and Rosovsky to Letters Regarding Article, "Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes From the S
   Circulation. 2026;154:e343-e344.
   

   >> Share

   
   
3. LYNCH PT, Makkapati S, George JC, Vaidya A, et al
   Left Circumflex Coronary-Pulmonary Arterial Collaterals in Chronic Thromboembolic Pulmonary Hypertension.
   Circulation. 2026;154:872.
   

   >> Share

   
   
4. WANG C, Wang H
   Letter by Wang and Wang Regarding Article, "Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes From the STORM-PE Trial".
   Circulation. 2026;154:e341-e342.
   

   >> Share

   
   July 2026
5. CREAGER MA, Barnes GD, Giri J, Mukherjee D, et al
   Correction to: 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/ SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical
   Circulation. 2026;154:e24.
   

   >> Share

   
   
6. STEG G
   Recurrent Venous Thromboembolism in Cancer: A Foreboding Event.
   Circulation. 2026 Jul 13. doi: 10.1161/CIRCULATIONAHA.126.082303.
   

   >> Share

   
   
7. MAHE I, Chapelle C, Righini M, Le Gal G, et al
   Prognosis of Recurrent Venous Thromboembolism During Extended Apixaban Therapy for Cancer-Associated Thrombosis: Insights From the API-CAT Randomized Trial.
   Circulation. 2026 Jul 13. doi: 10.1161/CIRCULATIONAHA.126.081437.
   

   >> Share

   
   February 2026
8. CREAGER MA, Barnes GD, Giri J, Mukherjee D, et al
   2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guideli
   Circulation. 2026 Feb 19. doi: 10.1161/CIR.0000000000001415.
   

   >> Share

   
   
9. TANG W, Li A, Austin TR, Braekkan SK, et al
   Novel Plasma Proteomic Markers and Risk of Venous Thromboembolism.
   Circulation. 2026 Feb 16. doi: 10.1161/CIRCULATIONAHA.125.074493.
   

   >> Share

   
   November 2025
10. LOOKSTEIN RA, Konstantinides SV, Weinberg I, Dohad SY, et al
    Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes from the STORM-PE Trial.
    Circulation. 2025 Nov 3. doi: 10.1161/CIRCULATIONAHA.125.077232.
    

    >> Share

    
    September 2025
11. WHITE RJ, Roto D, Lachant D
    Letter by White et al Regarding Article, "Large-Bore Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis in the Management of Intermediate-Risk Pulmonary Embolism: Primary Results of the PEERLESS Randomized Controlled Trial".
    Circulation. 2025;152:e269-e270.
    

    >> Share

    
    
12. JABER WA, Gonsalves CF, Stortecky S, Giri J, et al
    Response by Jaber et al to Letter Regarding Article, "Large-Bore Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis in the Management of Intermediate-Risk Pulmonary Embolism: Primary Results of the PEERLESS Randomized Controlled Trial".
    Circulation. 2025;152:e271-e272.
    

    >> Share

    
    
13. JI L, Zhang H
    Letter by Ji and Zhang Regarding Article, "Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)".
    Circulation. 2025;152:e90-e91.
    

    >> Share

    
    
14. HE Z, Wang C, Tian H
    Letter by He et al Regarding Article, "Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)".
    Circulation. 2025;152:e88.
    

    >> Share

    
    
15. LIU G, Fu C, Xie J
    Letter by Liu et al Regarding Article, "Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)".
    Circulation. 2025;152:e92-e93.
    

    >> Share

    
    
16. SANTINI P, Pola R
    Letter by Santini and Pola Regarding Article, "Rivaroxaban for 18 Months versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)".
    Circulation. 2025;152:e89.
    

    >> Share

    
    
17. YAMASHITA Y, Morimoto T, Kimura T
    Response by Yamashita et al to Letter Regarding Article, "Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)".
    Circulation. 2025;152:e94-e95.
    

    >> Share

    
    March 2025
18. TAKAHASHI EA, Sista AK, Addison D, Bikdeli B, et al
    Disparities in Current Pulmonary Embolism Management and Outcomes: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Mar 20. doi: 10.1161/CIR.0000000000001306.
    

    >> Share

    
    February 2025
19. RAO SV, Gutierrez JAT
    A Win for Clinical Evidence: The First Head-to-Head Trial of Interventional Strategies for the Treatment of Pulmonary Embolism.
    Circulation. 2025;151:274-276.
    

    >> Share

    
    November 2024
20. YAMASHITA Y, Morimoto T, Muraoka N, Shioyama W, et al
    Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial).
    Circulation. 2024 Nov 18. doi: 10.1161/CIRCULATIONAHA.124.072758.
    

    >> Share

    
    October 2024
21. JABER WA, Gonsalves CF, Stortecky S, Horr S, et al
    Large-bore Mechanical Thrombectomy Versus Catheter-directed Thrombolysis in the Management of Intermediate-risk Pulmonary Embolism: Primary Results of the PEERLESS Randomized Controlled Trial.
    Circulation. 2024 Oct 29. doi: 10.1161/CIRCULATIONAHA.124.072364.
    

    >> Share

    
    
22. DELCROIX M, Pepke-Zaba J, D'Armini AM, Fadel E, et al
    Worldwide CTEPH Registry: Long-Term Outcomes With Pulmonary Endarterectomy, Balloon Pulmonary Angioplasty, and Medical Therapy.
    Circulation. 2024;150:1354-1365.
    

    >> Share

    
    September 2024
23. ROSENFIELD K, Bowers TR, Barnett CF, Davis GA, et al
    Standardized Data Elements for Patients With Acute Pulmonary Embolism: A Consensus Report from the Pulmonary Embolism Research Collaborative.
    Circulation. 2024 Sep 12. doi: 10.1161/CIRCULATIONAHA.124.067482.
    

    >> Share

    
    
24. SINGH S, Kumar P, Padwad YS, Jaffer FA, et al
    Targeting Fibrinolytic Inhibition for Venous Thromboembolism Treatment: Overview of an Emerging Therapeutic Approach.
    Circulation. 2024;150:884-898.
    

    >> Share

    
    June 2024
25. 
    Correction to: Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association.
    Circulation. 2024;149:e1412.
    

    >> Share

    
    March 2024
26. AGGARWAL V, Giri J, Visovatti SH, Mahmud E, et al
    Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Mar 7. doi: 10.1161/CIR.0000000000001197.
    

    >> Share

    
    December 2023
27. OSTERGAARD L, Olesen JB, Petersen JK, Nielsen LS, et al
    Arterial Thromboembolism in Patients With Atrial Fibrillation and CHA(2)DS(2)-VASc 1: A Nationwide Study.
    Circulation. 2023 Dec 28. doi: 10.1161/CIRCULATIONAHA.123.066477.
    

    >> Share

    
    November 2023
28. GOTO S, Goto S
    Clinical Course of Isolated Distal Venous Thromboembolism in Patients With Active Cancer in a Nation With an Overall Low Risk of Thrombosis.
    Circulation. 2023;148:1677-1679.
    

    >> Share

    
    
29. HOSOKAWA K, Watanabe H, Taniguchi Y, Ikeda N, et al
    A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial.
    Circulation. 2023 Nov 13. doi: 10.1161/CIRCULATIONAHA.123.067528.
    

    >> Share

    
    March 2023
30. LASSEN MCH, Modin D, Skaarup KG, Johansen ND, et al
    Risk of Incident Thromboembolic and Ischemic Events After COVID-19 Vaccination Compared With SARS-CoV-2 Infection.
    Circulation. 2023;147:843-845.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share